NCT00779103View on ClinicalTrials.gov

Histrelin Subcutaneous Implant in Children With Central Precocious Puberty

PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

August 31, 2011

Study Completion Date

April 30, 2012

Conditions
Central Precocious Puberty
Interventions
DRUG

Histrelin Subcutaneous Implant

histrelin subcutaneous 50 mg implant

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY